Overview

Effects Of GW876008 On The Bowel In Patients With Irritable Bowel Syndrome

Status:
Completed
Trial end date:
2007-10-15
Target enrollment:
Participant gender:
Summary
The purpose of this study is to see if GW876008 in Irritable Bowel Syndrome patients will reverse stress-induced hypersensitivity, by looking at thresholds for perception and pain.
Phase:
Phase 2
Details
Lead Sponsor:
GlaxoSmithKline